Paris, France

Brigitte Demers

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2000-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Brigitte Demers: Innovator in Cancer Research

Introduction

Brigitte Demers is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer research through her innovative inventions. With a total of 3 patents, her work focuses on therapeutic combinations and methods for screening in the context of cancer treatment.

Latest Patents

One of her latest patents is titled "Combination comprising combretastatin and anticancer agents." This invention relates to therapeutic combinations that include VEGF Trap and a stilbene derivative, aimed at improving cancer treatment outcomes. Another notable patent is the "Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria." This invention involves mutant strains of gram-negative bacteria that can secrete proteins via the type III secretion machinery, providing a method for identifying molecules that can activate or inhibit this secretion process.

Career Highlights

Brigitte has worked with esteemed institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing our understanding of cancer therapies and bacterial mechanisms.

Collaborations

Throughout her career, Brigitte has collaborated with notable scientists, including Philippe J. Sansonetti and Claude Parsot. These collaborations have enriched her research and contributed to her innovative work in the field.

Conclusion

Brigitte Demers stands out as a key figure in cancer research, with her patents reflecting her commitment to advancing medical science. Her contributions continue to influence the development of effective cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…